Hidetake Nagahara
Kyoto, 6028566, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis.
Journal: Pulmonary pharmacology & therapeutics
Published: August 15, 2020
Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis.
Journal: Lung
Published: February 14, 2019
Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease.
Journal: Modern rheumatology
Published: November 27, 2018
Thermal and impact histories of 25143 Itokawa recorded in Hayabusa particles.
Journal: Scientific reports
Published: May 02, 2018
Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: December 08, 2017
Role of allograft inflammatory factor-1 in bleomycin-induced lung fibrosis.
Journal: Biochemical and biophysical research communications
Published: November 21, 2017
Efficacy of abatacept in patients with rheumatoid arthritis, as assessed by magnetic resonance imaging of bilateral hands.
Journal: International journal of rheumatic diseases
Published: July 22, 2017
Allograft inflammatory factor-1 in the pathogenesis of bleomycin-induced acute lung injury.
Journal: Bioscience trends
Published: February 26, 2016
Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 19, 2014
Last Updated: 09/26/2026